| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma
|
Gastaud, Lauris
|
|
2013
|
82 |
2 |
p. 362-364
3 p.
|
artikel
|
| 2 |
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer
|
Ciuleanu, T.
|
|
2013
|
82 |
2 |
p. 276-281
6 p.
|
artikel
|
| 3 |
A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment
|
Nishino, K.
|
|
2013
|
82 |
2 |
p. 299-304
6 p.
|
artikel
|
| 4 |
Assessment of palliative care for advanced non-small-cell lung cancer in France: A prospective observational multicenter study (GFPC 0804 study)
|
Vergnenègre, Alain
|
|
2013
|
82 |
2 |
p. 353-357
5 p.
|
artikel
|
| 5 |
Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors
|
Sun, Jong-Mu
|
|
2013
|
82 |
2 |
p. 294-298
5 p.
|
artikel
|
| 6 |
Combination of arsenic trioxide and chemotherapy in small cell lung cancer
|
Zheng, Chun-yan
|
|
2013
|
82 |
2 |
p. 222-230
9 p.
|
artikel
|
| 7 |
Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib
|
Tsai, Chun-Ming
|
|
2013
|
82 |
2 |
p. 305-312
8 p.
|
artikel
|
| 8 |
Contents
|
|
|
2013
|
82 |
2 |
p. v-vii
nvt p.
|
artikel
|
| 9 |
Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial
|
Hocking, William G.
|
|
2013
|
82 |
2 |
p. 238-244
7 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2013
|
82 |
2 |
p. iii-
1 p.
|
artikel
|
| 11 |
Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer
|
Sigel, Keith
|
|
2013
|
82 |
2 |
p. 266-270
5 p.
|
artikel
|
| 12 |
Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study
|
Mazières, Julien
|
|
2013
|
82 |
2 |
p. 231-237
7 p.
|
artikel
|
| 13 |
Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: A cancer registry study
|
Ball, David
|
|
2013
|
82 |
2 |
p. 358-361
4 p.
|
artikel
|
| 14 |
Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy
|
Vassalou, Helen
|
|
2013
|
82 |
2 |
p. 324-329
6 p.
|
artikel
|
| 15 |
Genetic alterations defining NSCLC subtypes and their therapeutic implications
|
Pikor, Larissa A.
|
|
2013
|
82 |
2 |
p. 179-189
11 p.
|
artikel
|
| 16 |
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
|
Berghmans, T.
|
|
2013
|
82 |
2 |
p. 340-345
6 p.
|
artikel
|
| 17 |
Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases
|
Hsiao, Shih-Hsin
|
|
2013
|
82 |
2 |
p. 319-323
5 p.
|
artikel
|
| 18 |
Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group
|
Armato III, Samuel G.
|
|
2013
|
82 |
2 |
p. 190-196
7 p.
|
artikel
|
| 19 |
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities
|
Shirvani, Shervin M.
|
|
2013
|
82 |
2 |
p. 252-259
8 p.
|
artikel
|
| 20 |
Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6
|
Abulaiti, Abulimiti
|
|
2013
|
82 |
2 |
p. 204-213
10 p.
|
artikel
|
| 21 |
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
|
Ashworth, Allison
|
|
2013
|
82 |
2 |
p. 197-203
7 p.
|
artikel
|
| 22 |
LKB1 mutant in a KRAS activated adenocarcinoma of the lung associated with Peutz–Jeghers syndrome: A case report
|
Zaba, O.
|
|
2013
|
82 |
2 |
p. 368-369
2 p.
|
artikel
|
| 23 |
Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib
|
Gautschi, Oliver
|
|
2013
|
82 |
2 |
p. 365-367
3 p.
|
artikel
|
| 24 |
Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis
|
Chen, Yan
|
|
2013
|
82 |
2 |
p. 313-318
6 p.
|
artikel
|
| 25 |
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status
|
Minami, Seigo
|
|
2013
|
82 |
2 |
p. 271-275
5 p.
|
artikel
|
| 26 |
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer
|
Mazzoni, Francesca
|
|
2013
|
82 |
2 |
p. 288-293
6 p.
|
artikel
|
| 27 |
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
|
Iuchi, T.
|
|
2013
|
82 |
2 |
p. 282-287
6 p.
|
artikel
|
| 28 |
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients
|
Vallée, Audrey
|
|
2013
|
82 |
2 |
p. 373-374
2 p.
|
artikel
|
| 29 |
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy
|
Lee, Shin Yup
|
|
2013
|
82 |
2 |
p. 330-339
10 p.
|
artikel
|
| 30 |
Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines
|
Shirsath, Nitesh
|
|
2013
|
82 |
2 |
p. 214-221
8 p.
|
artikel
|
| 31 |
Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: A multicenter analysis
|
Lococo, F.
|
|
2013
|
82 |
2 |
p. 245-251
7 p.
|
artikel
|
| 32 |
Serological investigation of the clinical significance of fascin in non-small-cell lung cancer
|
Teng, Yu
|
|
2013
|
82 |
2 |
p. 346-352
7 p.
|
artikel
|
| 33 |
Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitis
|
Yamaguchi, Shinsaku
|
|
2013
|
82 |
2 |
p. 260-265
6 p.
|
artikel
|
| 34 |
Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma
|
Watanabe, Satoshi
|
|
2013
|
82 |
2 |
p. 370-372
3 p.
|
artikel
|
Tijdschrift beschrijving